-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pralsetinib in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pralsetinib in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pralsetinib in Solid Tumor Drug Details: Pralsetinib (Gavreto) is an anticancer...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fidrisertib Succinate in Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fidrisertib Succinate in Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fidrisertib Succinate in Fibrodysplasia Ossificans Progressiva...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fisogatinib in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fisogatinib in Hepatocellular Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fisogatinib in Hepatocellular Carcinoma Drug Details: Fisogatinib (BLU-554) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LBL-007 in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LBL-007 in Laryngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LBL-007 in Laryngeal Cancer Drug Details: LBL-007 is under development for...
-
Product Insights
NewQuarterly Packaged Water pricing trends in Australia
Empower your strategies with our Quarterly Packaged Water pricing trends in Australia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Certepetide in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Certepetide in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Certepetide in Pancreatic Ductal Adenocarcinoma Drug Details: Certepetide (CEND-1) is...
-
Product Insights
NewQuarterly Packaged Water pricing trends in the United Arab Emirates
Empower your strategies with our Quarterly Packaged Water pricing trends in the United Arab Emirates report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Case Studies
Mountain Tourism – Case Study
Mountain Tourism Report Overview The mountain tourism case study offers detailed insights into the key destinations with opportunities and challenges faced by the industry. Mountains are important tourist destinations around the world and attract visitors for their picturesque beauty, sports attractions, and rich cultural and spiritual heritage. The expansion of transportation networks and digitalization has led to an increased interest in mountain tourism both for adventure and wellness. Mountain tourism allows tourists to witness and experience the environment in a...